|
|
Antonello Pileggi is a Research Assistant Professor in the Department of Surgery at the University of Miami Miller School of Medicine and the Director of Pre-clinical Cell Processing and Translational Models at the Diabetes Research Institute.
Dr. Pileggi’s primary research interests lie in transplantation immunobiology, autoimmunity and beta cell replacement therapies. His work focuses on developing cytoprotective strategies and maximizing the number and quality of transplantable islets. In addition, he is studying ways to improve long-term engraftment to reduce the number of islets needed for each transplant procedure.
As a key member of the DRI’s multidisciplinary task force, Dr. Pileggi is working to develop more sensitive tests to predict and assess islet viability. He contributes to the Institute’s research and academic activities including the development and testing of new transplant sites, cytoprotection, immunomodulation, tolerance, xenotransplantation, stem cell technology and clinical islet transplantation.
Dr. Pileggi received his medical degree from the University of Pavia Medical School in Italy. He subsequently earned his Ph.D. in Experimental and Microsurgery from the same institution.
Dr. Pileggi has authored many books and peer-reviewed publications in the field of organ and cellular transplantation, and has reviewed articles for several international scientific journals. He is a member of numerous scientific organizations and has served on research grant panels for international agencies.
|
>>Listen to podcast with Antonello Pileggi, M.D., Ph.D.
|
Share This Item
|